Follow The Trade Desk to never miss an important update.
The board of directors granted CEO Jeff Green a new performance-based stock option covering 7 million shares. These options only vest if the stock price hits seven specific targets over a ten-year period, starting at $18 and reaching as high as $105. For context, the stock currently trades around $15, meaning the first milestone requires a 20 percent gain and the final one requires the stock to rise sevenfold.
This plan is designed to tie the CEO's personal wealth directly to the returns of long-term owners. Because the options have an exercise price of $14.97, they are worthless unless the stock rises, and they only become available to him if the company sustains those higher prices for at least 20 consecutive trading days. It is a clear signal that the board and the founder are focused on a significant recovery in the stock price over the next decade.
Source: 8-K filing
The Trade Desk is deepening its ties with healthcare data firms Veeva Crossix and IQVIA. These integrations allow pharmaceutical companies to see more clearly how their digital ad spending leads to actual prescriptions or health outcomes. Healthcare is a highly regulated and specialized corner of the ad market. By building these specific tools, The Trade Desk makes its platform more useful for large drug makers who might otherwise stick to traditional TV or more limited ad networks. It is a small but logical step in the company's plan to win more spending from big brand advertisers.
Source: Business Wire
The Trade Desk is cutting about 15 percent of its staff as part of a plan to reorganize into smaller, more focused teams. This is a significant shift for a company that has historically avoided the large-scale layoffs seen at other big tech firms over the last few years.
While cutting costs can sometimes help profits in the short term, a layoff of this size often signals a change in how fast a company expects to grow. For a business built on scaling its software to handle billions of ad dollars, these cuts suggest management is tightening its belt to protect its margins as the digital ad market shifts.
Susquehanna lowered its rating on the company to neutral, a move that suggests they no longer see the stock as a clear buy. This change comes as the average price target from all analysts who follow the company has settled at $15.
When a major firm moves to the sidelines like this, it often reflects a view that the stock is fairly valued for now or that the path to higher profits has become less certain. While the company remains a leader in digital advertising software, this downgrade indicates that some professional analysts are becoming more cautious about its near-term growth.
The Trade Desk released Kokai Zuma, an update to its core software that brands use to buy digital ads. This version adds new AI tools designed to act like digital assistants, helping advertisers navigate the platform more easily and better understand how their ads are performing across different streaming services and websites.
This matters because as more TV moves to streaming, the process of buying ads is getting more complicated for big brands. By making its tools simpler and more automated, the company aims to keep advertisers spending on its platform rather than moving their budgets to rivals like Google or Meta.
Source: Business Wire
Management has missed its own profit targets in two of the last three quarters. This suggests the business is becoming harder to forecast as it shifts its focus toward restructuring.
| Expectation | |
|---|---|
| EPS | $0.05 |
| Revenue | $651M |
Follow The Trade Desk to get the latest and most important updates.
Follow TTD